How Indian pharmaceutical companies are supplying the U.S. with hydroxychloroquine after Western pharma has been trying to undermine Indian pharma for years.Michaela Stone Cross
It is not every day that the United States president asks another country for medical supplies.
But on Saturday, April 4, 2020, President Donald Trump called India Prime Minister Narendra Modi to request that India lift a ban on the export of antimalarial drug hydroxychloroquine (HCQ). The Food and Drug Administration (FDA) had declared it a potential treatment for COVID-19 and usage in the U.S. — the global epicenter of the coronavirus with over 560,000 confirmed cases — has spiked as panicked Americans scramble for a miracle cure. India, which produces 70% of the world’s supply, had banned exports of the drug except on “humanitarian grounds.”
“There may be retaliation,” Trump said at the White House press conference Monday when asked what would happen if Modi refused to export. “Why wouldn’t there be?”
The Juggernaut tells untold, smart South Asian stories and news you won't find anywhere else.
It’s like your other email briefings. But browner. Join thousands and get the best newsletter that curates the global news on South Asia(ns) every Sunday. We also send updates on events, giveaways, our original reporting, and more. Unsubscribe anytime.